INTRODUCTION
The cold-adapted B/Ann Arbor/l/66 influenza virus (ca B/AAI1/66) was developed as a source of attenuating genes for the production of live, type B influenza virus vaccines (Maassab and DeBorde, 1985) . The vaccine candidates produced in our laboratory are reassot-tants which inherit the six genes encoding the internal proteins from ca B/AA/l/66 and the hemagglutinin (HA) and neuraminidase (NA) genes from a relevant wild-type virus. Preliminary investigations indicate that vaccine candidate strains derived from ca B/AA/l/66 express stable attenuation in ferrets and humans (Davenport et al., 1977; Monto et a/., 1982; Reeve et a/., 1982) . In addition to attenuation, ca B/AA/l/66 expresses temperature-sensitive (ts) and cold-adapted (ca) phenotypes which are also transferred to reassortant progeny through the inheritance of ca B/AA/l/66 genes. A recent analysis of reassortant viruses has demonstrated that inheritance of the PA gene from ca B/AA/l/66 is necessary for the acquisition of the ts phenotype and is primarily but, not entirely, responsible for the expression of attenuated virulence in ferrets (Donabedian et al., 1987) .
Sequence analysis of ca B/AA/l/66 and its progenitor wild-type virus has revealed 105 nucleotide substi-1 To whom requests for reprints should be addressed.
tutions encoding 26 predicted amino acid substitutions to be present in the six "internal" protein genes of the ca virus. Of these, 17 nucleotide substitutions encoding six predicted amino acid substitutions reside in the ca B/AA/l/66 PA gene (DeBorde et al., 1988) . We are interested in identifying those substitutions in ca B/AA/l/66 which are responsible for the acquisition of temperature sensitivity and attenuated virulence in order to (1) investigate the potential stability of attenuation; (2) describe the underlying molecular basis for the expression of attenuated virulence; and (3) identify unambiguous markers of attenuation to be used in screening vaccine candidate strains. (Donabedian et al., 1987) . Since the ca B/AA/l/'66 PA gene is instrumental in the expression of the ts and attenuation phenotypes, this observation suggested that reversion of SG3 resulted from mutation of its PA gene.
The present report describes reassortment and sequence analysis of the SG3rFL revertant PA gene. In conjunction with the sequence determination of the wt and ca B/AA/l/66 PA genes (DeBorde et al., 1988) , these investigations have discounted the significance of extragenic suppression and allowed the identification of an attenuating lesion in the ca B/AA/l/66 PA protein.
MATERIALS AND METHODS

Viruses and cells
Influenza B virus reassortant SG3 was produced by reassortment of ca B/AA/l/66 and wt B/HN/1732/76 as described previously (Donabedian et al., 1987) . The virulent, non-ts revertant virus SG3rFL was recovered from the lungs of one ferret infected with SG3 (Donabedian et al., 1987) .
The preparation, maintenance, and infection of Madin-Darby canine kidney (MDCK) cells (Flow laboratories, Rockville, MD) and primary chick kidney (PCK) cells were described previously. (Maassab, 1969; Odagiri et al., 1982; Maassab and DeBorde, 1983 , 1987) . Virus pelleted from infected tissue culture media was resuspended in 300 ~1 of 0.3 n/lsodium acetate, pH 6.0, and incubated at 37" for 10 min in the presence of 500 pg/ml proteinase K. SDS was added to 0.5% and incubation was continued for 10 min. Viral RNA was precipitated overnight at -20" in 2.5 vol of 95% ethanol.
The parental origin of reassortant vRNA segments was determined by observing differential electrophoretie migration of labeled vRNA. Polyacrylamide gel electrophoresis was performed at 36-38" and 26" using mixed agarose-polyacrylamide gels as described previously (Donabedian et al., 1987) except that, in some instances, the stacking portion of the gel was omitted. The differences in migration between ca B/AA/l/66 and wt BlHNll732176 RNA segments were small, but consistently reproducible using this method. In addition, the origin of the PA gene was verified by sequence analysis after each reassortment experiment.
Virus infectivity titration and virulence assays
The titration of virus infectivity by plaque assay in MDCK cells and the evaluation of virulence in ferrets were performed exactly as described previously (Donabedian et al., 1987) .
Nucleotide sequence determination
The nucleotide sequences of the SG3, SG3rFI, MG123r45678, and SG3r PA genes were determined by a combination of three sequencing techniques. The first 40 nucleotides of the vRNA 3' termini of the SG3rFL PA gene was sequenced by the direct chemical method described by Peattie (1979) . RNA ligase end-labeling with [32P]cytidine bis-phosphate was performed as described by DeBorde et al. (1988) . The 3' Geliebter et al. (1986) . The remaining nucleotides were determined by dideoxynucleotide chain termination sequencing as described by DeBorde et al. (1986) and incorpora,ting terminal deoxynucleotidyl transferase enzyme to resolve all ambiguities.
RESULTS
Derivation of reassortants inheriting the revertant PA gene
The reversion of SG3 resulted from either mutation of the PA gene and/or extragenic suppressor mutations. Reassortment was employed, essentially, to replace the PA gene of SG3 with the revertant PA gene of SG3rFL in order to distinguish among these alternatives. In so doing, the revertant PA gene was segregated from ootential extragenic suppressor mutations (i.e., the remainder of the SG3rFL genome). Since only the PA and HA genes of SG3 and SG3rFL could be distinguished by electrophoresis, it was first necessary to transfer the revertant PA gene to a carrier virus, all of whose genes could be distinguished from those of SG3. For this purpose, a mating of SG3rFL and ca B/AA/l/66 was performed to derive MG123r45678. The subsequent transfer of the revertant PA gene required two successive matings with SG3. This reassortant strategy is summarized in Fig. 1 . On the basis of polyacrylamide gel electrophoresis, the resulting reassortanr (SG3r) was genetically equivalent to SG3 except for the difference detected in their PA genes. The gene compositions of these reassortants at 36" and 26" are shown in IFig. 2.
Phenotypic characterization of reassortants
The ts properties in MDCK cells of SG3r and its parental strains are shown in To determine whether mutation of the PA gene was associated with reversion to virulence, SG3r was adminstered to ferrets (Table 2) . Virulence was evaluated on the basis of fever and viral replication in the nasal turbinates and lungs. As with SG3rFL and wt B/HN/1732/76, SG3r grew well in the turbinates, induced a significant febrile response, and was isolated from the lungs at a similar frequency. Thus, mutation of the PA gene was sufficient for the reversion to virulence expressed by SG3rFL.
The , 1987) . Since the revertant PA gene lost the ability to confer these properties to a single gene reassortant (i.e., SG3r), this result suggested that the revertant PA gene retained one or more ts and attenuating mutations which were phenotypically expressed only in combination with other ca B/AA/l/66 genes.
Sequence analysis of the revertant PA gene
To identify the mutation(s) in the PA gene associated with phenotypic reversion, the complete nucleotide sequence of the SG3rFL PA gene was determined and compared with that of ca B/AA/i/66. Nucleotides 2-2306 of the SG3, MG123r45678, and SG3r PA genes were also sequenced to verify the identity of these genes.
The revertant PA genes of SG3rFL, MGl23r45678, and SG3r were distinguished from the PA genes of ca B/AA/l/66 and SG3 by only two nucleotide substitutions (Fig. 3) . As indicated in Table 3 , the substitution of uracil with cytosine at nucleotide 1886 did not alter the predicted amino acid sequence of the revertant PA protein. However, the substitution of guanine with adenine at nucleotide 1322 resulted in the predicted amino acid substitution of methionine in the PA protein of ca B/AA/l/66 with isoleucine in the revertant PA protein at residue 431. There was no obvious reason to conclude that a nucleotide substitution at a silent position in the body of the PA gene would be phenotypically expressed.
Thus, sequence analysis suggested that the single predicted amino acid substitution of methionine with isoleucine occurring at residue 43 1 in the PA gene of SG3 was responsible for its loss of the ts phenotype and the corresponding reversion to virulence.
DISCUSSION
Inheritance of the PA gene from ca B/AA/l/66 confers the ts phenotype and a significant degree of attenuated virulence to reassortant progeny using wt B/HN/1732/76 as the other parent (Donabedian et al., 1987) . The reversion of these phenotypes in a reassortant (SG3) inheriting only the PA gene from ca B/AA/l/66 was shown to result from mutation of this gene rather than as the result of extragenic suppression. The possibility that extragenic suppression was responsible for reversion was discounted by the inability of the revertant PA gene to confer the ts and attenuation phenoytpes in a genetic background equivalent to that of SG3. It is unlikely that SG3r possesses a "new" extragenic suppressor mutation since reassortment and biological cloning were performed at 33", a permissive temperature providing no selective advantage to non-ts progeny. Furthermore, polyacrylamide gel electrophoresis revealed no differences in migration of SG3 and SG3r gene segments apart from the PA gene.
The predicted amino acid sequence of the ca B/AA/i/66 PA protein is distinguished from that of the wt B/AA/l/66 PA protein by six amino acid substitutions, including a valine to methionine substitution at residue 43 1 (DeBorde et al., 1988) . At the protein level, reversion of the ts and attenuation phenotypes corresponded with the substitution of this methionine residue with isoleucine (Table 3 ). The loss of attenuation which resulted from this substitution established the involvement of the methionine residue at position 431 in the attenuation of ca B/AA/l/66 and its reassortants. In addition, this result demonstrated the absolute genetic correlation of attenuation and expression of the ts phenotype conferred by the PA protein gene of ca BIAAJlI66.
We interpret the expression of the ts and attenuation phenotypes by MG123r45678 as evidence for the presence of at least one additional attenuating mutation in the revertant PA gene (see Results). Such mutations would be expressed only in combination with one or more other ca B/AA/l/66 genes. Alternatively, it is possible that, in combination with other ca B/AA/l/ 66 genes, the isoleucine residue at position 43 1 in the Alternatively, the methionine residue at position 431 of the ca B/AA/l/66 PA protein may constitute the actual attenuating lesion. At the nucleotide level, reversion was associated with a guanine to adenine nucleotide substitution at position 1322 which modified the coding significance of the original adenine to guanine nucleotide substitution at position 1320 of the ca B/AA/l/66 PA gene (Table 3) . Thus, although the revertant PA gene retained the original mutation, reversion corresponded with the substitution of an amino acid at the same position as the original mutation. This substitution did not restore the original amino acid sequence, but may have led to a condition analogous to true reversion. isolates share some property which allows the PA proteins of these viruses to function efficiently at supraoptimal temperatures.
As described by Kyte and Doolittle (1982) the water-vapor free energies and interior-exterior distribution of amino acid side chains of valine and isoleucine are sufficiently similar to warrant assignment of the two highest hydropathy index values (4.2 and 4.5) to these residues. By these criteria, methio-nine is somewhat less hydrophobic (index value = 1.9). The effects of these differences are illustrated in Fig. 4 . Hydropathy plots representing the region of the wt B/AA/l/66 and revertant PA proteins around amino acid 431 are almost superimposable and both deviate from that of ca B/AAI1/66. Thus, we speculate that reversion may involve the restoration of hydrophobic character at this site.
Extragenic suppression is thought to occur through compensating alterations of a protein that is in physical contact with the product of the gene bearing the original mutation (Jarvik and Botstein, 1975) . By analogy, intragenic suppression may be thought to occur through compensating alterations at one location of a given protein that is in physical contact with a different location, bearing the original mutation, of the same protein. In this case, whether or not the revertant PA gene was intragenically suppressed, the mutation involving residue 431 identified a region of functional significance in the PA protein of influenza B viruses.
The three polymerase proteins of influenza B viruses are presumed to be the functional analogs of the influenza A polymerase proteins. The PA protein of influenza A viruses may be directly involved only in synthesis of the viral RNA genome (Krug et a/., 1975 were from the sequence data of DeBorde et al. (1988). homologous region in the PA proteins of influenza A and B viruses. Residues 42 l-432 of the wt B/AA/l/66 PA protein and residues 425-436 of the A/NT/60/68 PA protein are 75% homologous whereas, homology between these two proteins is 38% overall (DeBorde et al., 1987) .
Stable attenuation is a necessary component of a suitable live vaccine candidate. Since mutation is essentially a random event, it is impossible to ensure completely stable attenuation. However, the probability that mutation will result in a reversion to virulence is greatly diminished by the accumulation of attenuating mutations. It follows that the degree of stability can be estimated by determining the number of attenuating mutations present in a given virus (Scholtissek and Rott, 1984) . Thus, in the absence of procedures to incorporate site-directed mutations into viable negative-strand viruses, the isolation and analysis of revertants provides a useful method to investigate virulence and its attenuation at the level of protein structure.
